Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 1998

View Archived Issues

MitoKor and UCSF collaborate on Alzheimer's disease research

Guilford seeks licensing partner for Parkinson's disease diagnostic tool

Guilford offering two lead neuroprotective programs for licensing

Orally active and potent GH secretagogue discovered by Merck & Co.

Long-term financing plan for Genzyme Tissue Repair revealed

P&U identifies potent distamycin derivatives with improved therapeutic indices

Oncolym makes progress in phase II

Company Profile: Genome Pharmaceuticals

Final HOT Study results announced

Ebelactone B, a urinary kininase inhibitor, prevents salt-related hypertension in rats

Melatonin effective therapy for headache in patients with sleep phase delay syndrome

Antidiabetic activity of S-3483, a site-specific inhibitor of Glc-6-Pase

ABT-761: relationship between effect on exercise-induced bronchoconstriction and 5-LO inhibition

Dompe's novel antihistamine in phase I testing

Dual-action ACE/NEP inhibitors in the pipeline at Zambon

Research into new tocolytic agents continues at Merck & Co.

New HIV protease inhibitors reported by Searle

Kyowa Hakko claims new agents for thrombocytopenia

Irish research organization discovers MAO inhibitor with cytoprotective effects

Adolor in-licenses Roberts compound for narcotic-induced constipation

Abarelix poised to enter phase III clinical development

Famvir cleared by FDA for treatment of herpes in HIV-positive individuals

NDA submitted for new lung tumor imaging agent from Diatide

Angiotech's micellar paclitaxel enters clinic for arthritis

Second trial begins for DTI-136 in the treatment of liver cancer

Phase IIb results presented for pulmonary insulin

Zonagen reaches milestone for Vasomax

Karo Bio and the University of California expand license agreement

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...